Matchpoint Therapeutics secures $150 million in Series B financing led by Nextech Invest and Norwest. The funding will advance clinical development of MPT-062 for autoimmune and inflammatory diseases.
Amount Raised
$150 Million
Round Type
Series B
CambridgeHealthcareInvestors
Description
Matchpoint Therapeutics successfully closed a $150 million Series B financing to support the clinical development of its lead asset, MPT-062. The financing was co-led by Nextech Invest and Norwest, with participation from both new and existing investors. This funding will further progress Matchpoint's product pipeline, which includes innovative therapies for autoimmune and inflammatory diseases. The company looks forward to advancing its programs with the support of its investors.
Quick answer
Matchpoint Therapeutics raised $150 Million in a Series B round, dated October 7, 2026. Investors: Digitalis Ventures, Norwest Venture Partners, BB Biotech, Sanofi Ventures, Invus, T1D Fund, BOLD Longevity Growth and Access Biotechnology. Matchpoint Therapeutics is based in Cambridge, Massachusetts, United States.
- How much did Matchpoint Therapeutics raise?
- Matchpoint Therapeutics raised $150 Million in a Series B round on October 7, 2026.
- Who invested in Matchpoint Therapeutics?
- Digitalis Ventures, Norwest Venture Partners, BB Biotech, Sanofi Ventures, Invus, T1D Fund, BOLD Longevity Growth and Access Biotechnology are named as investors in this round.
- What does Matchpoint Therapeutics do?
- Matchpoint is a biotechnology company harnessing the power of covalency to discover precision covalent medicines to transform the treatment of immune diseases and other serious illnesses.
- Where is Matchpoint Therapeutics based and how big is it?
- Matchpoint Therapeutics is based in Cambridge, Massachusetts, United States. Fundz records about 32 employees.
- Who are the decision-makers at Matchpoint Therapeutics?
- Fundz holds 1 contact at Matchpoint Therapeutics, including the Senior Vice President, Head of Platform and Chemical Biology. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Healthcare around the same time
Companies in the same sectors as Matchpoint Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Francis Medical raised an undisclosed amount on November 12, 2026.
- XpertDox LLC raised $20M (Series A) on November 11, 2026.
- Zus Health raised $33M (Series B) on November 10, 2026.
- Silo Pharma raised $815K (Post-IPO Equity) on November 6, 2026.
- Annovis Bio raised $21M (Post-IPO Equity) on November 5, 2026.
- Equinox raised $1B on November 2, 2026.
Who to call at Matchpoint Therapeutics, and when
A new round usually means Matchpoint Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Matchpoint Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Matchpoint Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Matchpoint Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Matchpoint Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansMatchpoint Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.